Trials / Unknown
UnknownNCT00925223
Brain-derived Neurotrophic Factor Participates in Visceral Hyperalgesia in Irritable Bowel Syndrome (IBS) Patients
Study of Brain-derived Neurotrophic Factor in Visceral Hyperalgesia in IBS Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Shandong University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Brain-derived neurotrophic factor (BDNF), originally known to be a member of the nerve growth factor family, has aroused attention as a modulator in visceral hyperalgesia recently. Visceral hypersensitivity is recognized as a clinical hallmark in IBS patients. So in this study, the investigators will focus on the role of BDNF in colonic hyperalgesia in IBS patients.
Conditions
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2009-08-01
- Completion
- 2009-11-01
- First posted
- 2009-06-22
- Last updated
- 2009-10-14
Source: ClinicalTrials.gov record NCT00925223. Inclusion in this directory is not an endorsement.